Nardone, V., Giannicola, R., Bianco, G., Giannarelli, D., Tini, P., Pastina, P., . . . Correale, P. (2021). Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade. Front Oncol.
Chicago-стиль цитированияNardone, Valerio, et al. "Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade." Front Oncol 2021.
MLA-цитированиеNardone, Valerio, et al. "Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade." Front Oncol 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.